Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy Study of Pl-vegf165 to Treat Diabetic Foot Syndrome

NCT02538705 is registered in ClinicalTrials.gov with Artgen Biotech as lead sponsor.

NCT NCT02538705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02538705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy Study of Pl-vegf165 to Treat Diabetic Foot Syndrome
Lead sponsor
Artgen Biotech
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2015
Completion date
January 1, 2016
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ulcers related to diabetic foot syndrome